Company Overview of Anterion Therapeutics, Inc.
Anterion Therapeutics, Inc. engages in the research, development, preclinical and human testing, manufacturing, and licensing of sustained release drug delivery systems primarily in the form of bioerodible implants. Its products include Choless, an implant for lowering bad cholesterol and triglycerides without affecting good cholesterol; Annuelle, a female contraceptive; MasQcept, a male contraceptive; Compliemens, an estrogen implant for the treatment of vaso-motor effects of menopause; Reproxine, a replacement of thyroid hormone; and Ambulin and other peptides for enhancing the growth level of hormones. The company was founded in 2003 and is based in Salem, Massachusetts.
35 Congress Street
Salem, MA 01970
Founded in 2003
Key Executives for Anterion Therapeutics, Inc.
Anterion Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
To contact Anterion Therapeutics, Inc., please visit www.anterion.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.